123 related articles for article (PubMed ID: 15548982)
1. Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts.
Grinyó JM; Cruzado JM; Millán O; Caldés A; Sabaté I; Gil-Vernet S; Serón D; Brunet M; Campistol JM; Torras J; Martorell J
Transplantation; 2004 Nov; 78(9):1400-3. PubMed ID: 15548982
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil.
Millán O; Brunet M; Campistol JM; Faura A; Rojo I; Vidal E; Jiménez O; Vives J; Oppenheimer F; Martorell J
Clin Chem; 2003 Nov; 49(11):1891-9. PubMed ID: 14578321
[TBL] [Abstract][Full Text] [Related]
3. C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients.
Barten MJ; Rahmel A; Garbade J; Richter M; Bittner HB; Dhein S; Mohr FW; Gummert JF
Transplant Proc; 2005 Mar; 37(2):1360-1. PubMed ID: 15848720
[TBL] [Abstract][Full Text] [Related]
4. Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients.
Schrama YC; Joles JA; van Tol A; Boer P; Koomans HA; Hené RJ
Transplantation; 2000 Feb; 69(3):376-83. PubMed ID: 10706046
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
6. Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function.
Hueso M; Bover J; Serón D; Gil-Vernet S; Sabaté I; Fulladosa X; Ramos R; Coll O; Alsina J; Grinyó JM
Transplantation; 1998 Dec; 66(12):1727-31. PubMed ID: 9884267
[TBL] [Abstract][Full Text] [Related]
7. New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.
Brunet M; Millán O; Jiménez O; Campistol JM; Vidal E; Rojo I; Oppenheimer F; Fortuna V; Martorell J
Transplant Proc; 2004 Mar; 36(2 Suppl):437S-441S. PubMed ID: 15041382
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil.
Miroux C; Morales O; Ouaguia L; Aoudjehane L; Boleslawski E; Pancré V; de Launoit Y; Calmus Y; Conti F; Delhem N
Transplant Proc; 2012 Nov; 44(9):2834-9. PubMed ID: 23146536
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
[TBL] [Abstract][Full Text] [Related]
11. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; IJzermans JN; Weimar W
Transplantation; 2000 Jul; 70(1):143-8. PubMed ID: 10919591
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: a retrospective analysis.
Benz K; Plank C; Griebel M; Montoya C; Dötsch J; Klare B
Pediatr Transplant; 2006 May; 10(3):331-6. PubMed ID: 16677357
[TBL] [Abstract][Full Text] [Related]
13. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
Cortinovis M; Gotti E; Pradini S; Gaspari F; Perico N
Transplantation; 2011 Sep; 92(5):550-6. PubMed ID: 21709602
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial.
Åsberg A; Apeland T; Reisaeter AV; Foss A; Leivestad T; Heldal K; Thorud LO; Eriksen BO; Hartmann A;
Clin Transplant; 2013; 27(2):E151-6. PubMed ID: 23351013
[TBL] [Abstract][Full Text] [Related]
15. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine and mycophenolate mofetil 48 hours before renal transplantation enables the use of low cyclosporine doses and achieves better graft function.
Maamoun H; Soliman A; Zayed B
Transplant Proc; 2010 Dec; 42(10):4033-6. PubMed ID: 21168619
[TBL] [Abstract][Full Text] [Related]
17. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.
Rentenaar RJ; van Diepen FN; Meijer RT; Surachno S; Wilmink JM; Schellekens PT; Pals ST; van Lier RA; ten Berge IJ
Kidney Int; 2002 Jul; 62(1):319-28. PubMed ID: 12081594
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
19. Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil.
Nadeau KC; Azuma H; Tilney NL
Transplantation; 1996 Nov; 62(9):1363-6. PubMed ID: 8932288
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.
Zanker B; Schneeberger H; Rothenpieler U; Hillebrand G; Illner WD; Theodorakis I; Stangl M; Land W
Transplantation; 1998 Jul; 66(1):44-9. PubMed ID: 9679820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
